Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX03V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Mon, 14 Jan 2002 23:56:03 -0800
Received: from corp.enron.com ([192.168.110.226]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 15 Jan 2002 01:55:10 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a365559c0a86ee241c@corp.enron.com> for <tkuyken@exchange.enron.com>;
 Tue, 15 Jan 2002 01:54:17 -0600
Received: from mailman.enron.com ([61.141.139.144])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl24797
        for <tkuyken@enron.com>; Tue, 15 Jan 2002 01:52:20 -0600 (CST)
Received: from cuesticksonline.com ([213.130.63.235])
          by pad.evergreen-systems.com
          (InterMail vK.4.04.00.00 220-885-993 license 0ib796fi4130k3lm3g9pit1705r4zel0)
          with ESMTP id <20038725909135.MQYP2730.buxton@cuesticksonline.com>
          for <tkuyken@enron.com>; Tue, 15 Jan 2002 08:03:44 -0100
Date: Tue, 15 Jan 2002 06:01:44 -0300
From: "Terrence Frank" <xqergj@frozengraphics.com>
Subject: Otc-guide on great investment
X-Originating-IP: [199.181.164.54]
To: <tkuyken@enron.com>
Message-ID: <171717386495.DGX66255@owing.evergreen-systems.com>
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.6990.24)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: eft@cuesticksonline.com
X-StarScan-Version: 5.4.51; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;tkuyken@enron.com

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 90,0OO,00O EST
Current Price: O.11
20O4 Success lead into an exciting 20O5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9O01 industrial certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Included in the stable of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be||adonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydrochlorrde, 10-Deacety| Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2O00 with a view to become 
a cost effective producer and supplier of bu|k Pharmaceutical and 
Neutraceutical products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy re|ating to the production of Rutin.

Rutin is a member of biof|avonoids, a large grOup of phenolic secondary 
metabolites of plants that include more than 2,000 different known 
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeability of the walls of the b|ood vesse|s inc|uding capi||aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate re|ations with 
Chinese governmenta| agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Estimated revenues for 2OO4-20O5 are more then  $100 mil|i0n USD

Further developments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conc|usion:

The Examp|es Above Show The Awesome, Earning Potential of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Tuesday! Go SCRE.

Penny stOcks are considered high|y speculative and may be unsuitab|e 
for al| but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 3OO0 dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mailings, or if you fee| you have been
wrongfu||y p|aced in our membership, p|ease go here or send a blank
e mai| with No Thanks in the subject to   st0ck1001 @  yahoo.com      
